• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MENAQUINONE 4
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION & THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ADROPIN
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • ADDICTION & DOPAMINE
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • ANXIOLYTIC
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BIOMIMETIC HYDROXYAPATITE
      • BMI-1
      • BPA & OBESITY
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CDK5
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DEPERSONALIZATION
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENDOCRINE DISRUPTING CHEMICALS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING & THE BRAIN
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUCOCORTICOID RECEPTOR ACTIVATION
      • GLUTAMATE & BRAIN
      • GLYCATION
      • GUT BRAIN AXIS
      • KLOTHO
      • K OPIOD RECEPTOR & ADDICTION
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HAIR REPIGMENTATION
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERALGESIA
      • HYPERINSULINEMIA
      • HYPOTHALAMIC PITUITARY ADRENAL HPA AXIS
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INSULIN OXIDATIVE STRESS
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NEUTRALIZING OXIDATIVE STRESS WITH MEDICINAL PLANTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR & FEAR
      • NON OPIOD ANALGESICS
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • OBESOGENS
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • POLYPHENOLS AS COVID-19 TREATMENT & PREVENTION
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SEX HORMONE BINDING GLOBULIN
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • THROMBOLYTICS (PLANT BASED)
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
      • XENOBIOTICS
      • XENOESTROGEN
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    ADAPTOGENS
    April 14, 2021
    NEUROPROTECTIVE AGENTS
    April 14, 2021
    1. Flavonoids—chemistry, metabolism, Cardioprotective effects, and dietary sources
    2. Effect of ibuprofen on Cardioprotective effect of aspirin
    3. Opposing Cardioprotective actions and parallel hypertrophic effects of δPKC and ɛPKC
    4. Evidence for the Cardioprotective effects of omega-3 fatty acids
    5. ATP-sensitive potassium channels: a review of their Cardioprotective pharmacology
    6. Cardioprotective effects of light–moderate consumption of alcohol: a review of putative mechanisms
    7. Cardioprotective actions by a water-soluble carbon monoxide–releasing molecule
    8. Randomised controlled trial of Cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up.
    9. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes
    10. Na+/h+exchange inhibitors for Cardioprotective therapy: progress, problems and prospects
    11. Cardiac risk factors and the use of Cardioprotective medications in patients with chronic renal insufficiency
    12. Growth hormone-independent Cardioprotective effects of hexarelin in the rat
    13. Therapeutic value of a Cardioprotective agent in patients with severe ischaemic cardiomyopathy
    14. Heart rate variability and heart rate in healthy volunteers. Is the female autonomic nervous system Cardioprotective?
    15. Cardioprotective effects of 70-kDa heat shock protein in transgenic mice
    16. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion
    17. Cardioprotective effects of trimetazidine: a review
    18. Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury
    19. Cardioprotective and Anti-oxidant Effects of the Terpenoid Constituents ofGinkgo bilobaExtract (EGb 761)
    20. Potential Cardioprotective actions of no-releasing aspirin
    21. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research
    22. The possible implication of trans-resveratrol in the Cardioprotective effects of long-term moderate wine consumption
    23. High level of physical activity preserves the Cardioprotective effect of preinfarction angina in elderly patients
    24. Cardioprotective Effect of Diazoxide and Its Interaction With Mitochondrial ATP-Sensitive K+ Channels: Possible Mechanism of Cardioprotection
    25. Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it Cardioprotective in patients with angina?
    26. Mildronate: Cardioprotective action through carnitine-lowering effect
    27. Simvastatin exerts both anti-inflammatory and Cardioprotective effects in apolipoprotein E–deficient mice
    28. … of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease insights into the Cardioprotective effect of certain …
    29. Cardioprotective effect of tender coconut water in experimental myocardial infarction
    30. 17β-Estradiol as a receptor-mediated Cardioprotective agent
    31. Synthesis of some hydroxynaphthazarins and their Cardioprotective effects under ischemia-reperfusion in vivo
    32. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion.
    33. Aging reduces the Cardioprotective effect of ischemic preconditioning in the rat heart
    34. Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling
    35. The Cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress
    36. Morphine mimics the Cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart
    37. Sildenafil (Viagra) induces powerful Cardioprotective effect via opening of mitochondrial KATP channels in rabbits
    38. Why Are Some Individuals Resistant to the Cardioprotective Effects of Aspirin? Could It Be Thromboxane A2?
    39. Randomized trial of the Cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.
    40. Role of AT2 Receptors in the Cardioprotective Effect of AT1 Antagonists in Mice
    41. Cardioprotective potential of Ocimum sanctum in isoproterenol induced myocardial infarction in rats
    42. Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion
    43. A potential Cardioprotective role of hepatocyte growth factor in myocardial infarction in rats
    44. Direct vascular and Cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor
    45. RETRACTED: adaptogenic and Cardioprotective action of ashwagandha in rats and frogs
    46. Cardioprotective effects of chronic hypoxia and ischaemic preconditioning are not additive
    47. Doxorubicin administration by continuous infusion is not Cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol
    48. Cardioprotective Effects of the Na+/H+ Exchange Inhibitor Cariporide in Patients With Acute Anterior Myocardial Infarction Undergoing Direct PTCA
    49. Antianginal and Cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease.
    50. … eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction: Results of the evaluation of the safety and Cardioprotective effects of eniporide in …
    51. Comparison of Cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats
    52. Insulin administered at reoxygenation exerts a Cardioprotective effect in myocytes by a possible anti-apoptotic mechanism
    53. Nicorandil, a potent Cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels
    54. Basic fibroblast growth factor is Cardioprotective in ischemia-reperfusion injury
    55. Cardioprotective effect of trimetazidine during coronary artery graft surgery.
    56. The role of bradykinin and nitric oxide in the Cardioprotective action of ACE inhibitors
    57. Cardioprotective actions of garlic (Allium sativum).
    58. The vascular activity of some isoflavone metabolites: implications for a Cardioprotective role
    59. Cardioprotective actions of wild garlic (Allium ursinum) in ischemia and reperfusion
    60. Direct vascular antiatherogenic effects of oleic acid: a clue to the Cardioprotective effects of the Mediterranean diet.
    61. Cardioprotective effect of chronic hypoxia is blunted by concomitant hypercapnia
    62. Opening of mitochondrial KATPchannel induces early and delayed Cardioprotective effect: role of nitric oxide
    63. Elevated heart rate variability in physically active postmenopausal women: a Cardioprotective effect?
    64. Molecular transporters for peptides: delivery of a Cardioprotective ϵPKC agonist peptide into cells and intact ischemic heart using a transport system, R7
    65. Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoids
    66. Cardioprotective actions of endogenous IL-10 are independent of iNOS
    67. Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis
    68. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?
    69. Improved synthetic methods of CP-060S, a novel Cardioprotective drug
    70. Differential actions of Cardioprotective agents on the mitochondrial death pathway
    71. Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice
    72. Harnessing an endogenous Cardioprotective mechanism: cellular sources and sites of action of adenosine
    73. Cardioprotective effects of transforming growth factor-β1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK
    74. Cardioprotective effects of Picrorrhiza kurroa against isoproterenol-induced myocardial stress in rats
    75. Mechanism of the Cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion.
    76. Preclinical profile of zofenopril: an angiotensin converting enzyme inhibitor with peculiar Cardioprotective properties
    77. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury
    78. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion.
    79. Cardioprotective effect of adrenomedullin in heart failure
    80. Phosphocreatine: molecular and cellular aspects of the mechanism of Cardioprotective action
    81. In vitro enzyme inhibitory and in vivo Cardioprotective activities of hibiscus (Hibiscus sabdariffa L.)
    82. Kinetics of tumor necrosis factor α in plasma and the Cardioprotective effect of a monoclonal antibody to tumor necrosis factor α in acute myocardial infarction
    83. Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat
    84. Complementary Cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion
    85. ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel Cardioprotective role of ATF3
    86. Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is Cardioprotective
    87. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury.
    88. Cardioprotective effects of KB-R7943: a novel inhibitor of the reverse mode of Na+/Ca2+exchanger
    89. The Cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart
    90. Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion
    91. The Cardioprotective effects of ischemic’preconditioning’are not mediated by adenosine receptors in rat hearts.
    92. The Cardioprotective effect of Mn-superoxide dismutase is lost at high doses in the postischemic isolated rabbit heart
    93. Ischemic preconditioning is not Cardioprotective in senescent human myocardium
    94. Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase
    95. Paracrine systems in the Cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats
    96. Blocking Na+–H+ exchange by cariporide reduces Na+-overload in ischemia and is Cardioprotective
    97. Activation of ɛ protein kinase C correlates with a Cardioprotective effect of regular ethanol consumption
    98. Mechanism of Cardioprotective effect of orotic acid
    99. Monohydroxyethylrutoside, a dose-dependent Cardioprotective agent, does not affect the antitumor activity of doxorubicin.
    100. Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart
    101. Novel small molecule inhibitor of C1s exerts Cardioprotective effects in ischemia-reperfusion injury in rabbits
    102. Cardioprotective effects of 17β-estradiol produced by activation of mitochondrial ATP-sensitive K+ channels in canine hearts
    103. Manganese Dipyridoxyl Diphosphate: MRI Contrast Agent with Antioxidative and Cardioprotective Properties?: In Vitroandex VivoAssessments
    104. Cardioprotective effects of nicorandil.
    105. Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart
    106. Cardioprotective effects of adenosine A1 and A 3 receptor activation during hypoxia in isolated rat cardiac myocytes
    107. Opening of potassium channels: the common Cardioprotective link between preconditioning and natural hibernation?
    108. Cardioprotective effects of extracts from Psidium guajava L. and Limonium wrightii, Okinawan medicinal plants, against ischemia-reperfusion injury in perfused rat …
    109. Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury
    110. Measurement of troponin T to detect Cardioprotective effect of trimetazidine during coronary artery bypass grafting
    111. Cardioprotective effects of diltiazem infusion in the perioperative period
    112. TAT protein transduction into isolated perfused hearts: TAT–apoptosis repressor with caspase recruitment domain is Cardioprotective
    113. Ischemic preconditioning: nature’s own Cardioprotective intervention
    114. Distinct Cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D
    115. Cardioprotective effect of ischemic preconditioning is preserved in food-restricted senescent rats
    116. Effects of a novel Cardioprotective drug, JTV-519, on membrane currents of guinea pig ventricular myocytes
    117. A new Cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure
    118. Aspirin alters the Cardioprotective effects of the factor XIII Val34Leu polymorphism
    119. Clinical trial evidence for the Cardioprotective effects of omega-3 fatty acids
    120. Cardioprotective effects of ovarian hormones
    121. Niacin, but not gemfibrozil, selectively increases LP-AI, a Cardioprotective subfraction of HDL, in patients with low HDL cholesterol
    122. Cardioprotective activity of synthetic guggulsterone (E and Z-isomers) in isoproterenol induced myocardial ischemia in rats: a comparative study
    123. Delayed Cardioprotective effects of exercise in dogs are aminoguanidine sensitive: possible involvement of nitric oxide
    124. Role of Kinins in the Cardioprotective Effect of Preconditioning: Study of Myocardial Ischemia/Reperfusion Injury in B2 Kinin Receptor Knockout Mice and Kininogen …
    125. A novel Cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia
    126. … inhibitor ramipril is more effective than the b-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril Cardioprotective …
    127. KATP Channel Gene Expression Is Induced by Urocortin and Mediates Its Cardioprotective Effect
    128. C-peptide exerts Cardioprotective effects in myocardial ischemia-reperfusion
    129. Cyclooxygenase-2 mediates the Cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits
    130. Hypothermic, closed circuit pericardioperfusion: a potential Cardioprotective technique in acute regional ischemia
    131. Diminished Cardioprotective Response to Inhibition of Angiotensin-Converting Enzyme and Angiotensin II Type 1 Receptor in B2 Kinin Receptor Gene Knockout …
    132. Cardioprotective effects of N-acetylcysteine: the reduction in the extent of infarction and occurrence of reperfusion arrhythmias in the dog
    133. Cardioprotective effects of volatile anesthetics in cardiac surgery
    134. S-nitrosoglutathione improves functional recovery in the isolated rat heart after cardioplegic ischemic arrest-evidence for a Cardioprotective effect of nitric oxide.
    135. Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation
    136. Cardioprotective Effects of Propofol and Sevoflurane in Ischemic and Reperfused Rat Hearts Role of KATPChannels and Interaction with the Sodium …
    137. Cardiac natriuretic peptides: a physiological lineage of Cardioprotective hormones?
    138. Molecular and cellular aspects of the Cardioprotective mechanism of phosphocreatine
    139. A novel Cardioprotective role of RhoA: new signaling mechanism for adenosine
    140. Cardioprotective abilities of white wine
    141. Differing Cardioprotective efficacy of the Na+/Ca2+ exchanger inhibitors SEA0400 and KB-R7943
    142. Phosphorylation of glycogen synthase kinase-3β during preconditioning through a phosphatidylinositol-3-kinase–dependent pathway is Cardioprotective
    143. Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the Cardioprotective effect of ethanol
    144. Is adenosine preconditioning truly Cardioprotective in coronary artery bypass surgery?
    145. Protein kinase C activation and Cardioprotective effect of preconditioning with oxidative stress in isolated rat heart
    146. Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: importance of kinins and influence on angiotensin II type 1 receptor …
    147. Cardioprotective effects and the mechanisms of terminal warm blood cardioplegia in pediatric cardiac surgery
    148. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the Cardioprotective effects observed with the …
    149. The Cardioprotective effect of sevoflurane depends on protein kinase C activation, opening of mitochondrial K+ ATP channels, and the production of reactive oxygen …
    150. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction
    151. Cardioprotective effect of prior β-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in …
    152. The metabolites of the Cardioprotective drug dexrazoxane do not protect myocytes from doxorubicin-induced cytotoxicity
    153. … related compounds decrease membrane fluidity in liposomes: Mechanism for the antioxidant action of tamoxifen and relevance to its anticancer and Cardioprotective …
    154. Contribution of bradykinin to the Cardioprotective effects of ACE inhibitors
    155. Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats
    156. Pharmacokinetic analysis of the Cardioprotective effect of 3-(2, 2, 2-trimethylhydrazinium) propionate in mice: inhibition of carnitine transport in kidney
    157. The cost and Cardioprotective effects of enalapril in hypertensive patients with left ventricular dysfunction
    158. Quinolones: Cardioprotective or cardiotoxic?
    159. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes
    160. Angiotensin-(1-7): Cardioprotective effect in myocardial ischemia/reperfusion
    161. Cardioprotective effect of succinate against ischemia/reperfusion injury.
    162. Antioxidants in medicines and spices as Cardioprotective agents in Tibetan highlanders
    163. Cardiovascular and biological effects of K+ channel openers, a class of drugs with vasorelaxant and Cardioprotective properties
    164. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a Cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of …
    165. Glyburide, a KATP channel antagonist, attenuates the Cardioprotective effects of isoflurane in stunned myocardium
    166. In vitro and in vivo studies on the Cardioprotective action of oligomeric procyanidins in a Crataegus extract of leaves and blooms
    167. Cardioprotective actions of acute HMG‐CoA reductase inhibition in the setting of myocardial infarction
    168. Endocrine, metabolic and Cardioprotective effects of hexarelin in obese Zucker rats
    169. The role of in-hospital initiation of Cardioprotective therapies to improve treatment rates and clinical outcomes
    170. Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas’ disease
    171. Cardioprotective effects of lidoflazine in extensive aorta-coronary bypass grafting
    172. Cardioprotective effect of TY-12533, a novel Na+/H+ exchange inhibitor, on ischemia/reperfusion injury
    173. Reactions of indole derivatives with Cardioprotective activity with reactive oxygen species. Comparison with melatonin
    174. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
    175. Cardiovascular risk in dialysis patients: a comparison of risk factors and Cardioprotective therapy between 1996 and 2001
    176. Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury
    177. Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat …
    178. Cardioprotective effects of vasopeptidase inhibitors.
    179. The interaction of the Cardioprotective agent ICRF-187 ((+)-1, 2-bis (3, 5-dioxopiperazinyl-1-yl) propane); its hydrolysis product (ICRF-198); and other chelating agents …
    180. The Cardioprotective effects of nitroglycerin-induced preconditioning are mediated by calcitonin gene-related peptide
    181. Cardioprotective effects of Cichorium intybus in ageing myocardium of albino rats
    182. Possible mechanism of Cardioprotective effect of ischaemic preconditioning in isolated rat heart
    183. Receptor-mediated Cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit.
    184. Cardioprotective effects of selective inhibition of the two complement activation pathways in myocardial ischemia and reperfusion injury.
    185. Lack of Cardioprotective efficacy of allopurinol in coronary artery surgery.
    186. The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a Cardioprotective factor
    187. Novel Cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation
    188. Translation of PDGF Cardioprotective pathways
    189. Protein Kinase C ε–Src Modules Direct Signal Transduction in Nitric Oxide–Induced Cardioprotection: Complex Formation as a Means for Cardioprotective Signaling
    190. Innate immunity and cardiac preconditioning: a putative intrinsic Cardioprotective program
    191. Pharmacodynamics of the hydrolysis‐activation of the Cardioprotective agent (+)‐1, 2‐bis (3, 5‐dioxopiperazinyl‐1‐yl) propane
    192. Involvement of nitric oxide in Cardioprotective effect of endothelin receptor antagonist during ischemia-reperfusion
    193. The Cardioprotective agent urocortin induces expression of CT-1
    194. Zinc accumulation in adriamycin‐induced cardiomyopathy in rats: Effects of melatonin, a Cardioprotective antioxidant
    195. Cardioprotective effects of monophosphoryl lipid A, a novel endotoxin analogue, in the dog
    196. Cardioprotective effect induced by brief exposure to nitric oxide before myocardial ischemia–reperfusion in vivo
    197. Cardioprotective effects of citrulline in ischemia/reperfusion injury via a non-nitric oxide-mediated mechanism.
    198. 3-(2, 2, 2-Trimethylhydrazinium) propionate (thp)-a novel γ-butyrobetaine hydroxylase inhibitor with Cardioprotective properties
    199. Nicorandil, a potent Cardioprotective agent, reduces QT dispersion during coronary angioplasty
    200. Glyburide-reversible Cardioprotective effect of BMS-180448 is independent of action potential shortening
    201. Cardioprotective action of CRF peptide urocortin against simulated ischemia in adult rat cardiomyocytes
    202. Mechanism of Cardioprotective action of TNF-α in the isolated rat heart
    203. Cardioprotective EFFECTS OF ADENOSINE A1AND A2ARECEPTOR AGONISTS IN THE ISOLATED RAT HEART
    204. The Cardioprotective effect of wine on human blood chemistry
    205. Cardioprotective effects of morphine on rat heart suffering from ischemia and reperfusion.
    206. Survival of the fittest: evidence for high-risk and Cardioprotective fitness levels
    207. Pertussis toxin abolishes the Cardioprotective effect of ischemic preconditioning in intact rat heart
    208. Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil Strain): an …
    209. Cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides.
    210. Unique Cardioprotective action of the new calcium antagonist mibefradil
    211. Cardioprotective actions of taurine against intracellular and extracellular calcium-induced effects
    212. Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein
    213. Cardioprotective effects of the cyanoguanidine potassium channel opener P-1075.
    214. Antiarrhythmic effects of JTV‐519, a novel Cardioprotective drug, on atrial fibrillation/flutter in a canine sterile pericarditis model
    215. The anti-infarct effect of an adenosine A1-selective agonist is diminished after prolonged infusion as is the Cardioprotective effect of ischaemic preconditioning in rabbit …
    216. The Cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.
    217. Animal models of anthracycline cardiotoxicity: Basic mechanisms and Cardioprotective activity
    218. Vintners and vasodilators: are French red wines more Cardioprotective?
    219. Clinical pharmacology of estrogens: cardiovascular actions and Cardioprotective benefits of replacement therapy in postmenopausal women
    220. The one-ring open hydrolysis product intermediates of the Cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexes
    221. ATP-sensitive K+ Channels Mediate the Delayed Cardioprotective Effect of Adenosine A1Receptor Activation
    222. Cardioprotective effects of lowering oxygen tension after aortic unclamping on cardiopulmonary bypass during coronary artery bypass grafting
    223. Involvement of oxygen free radicals in Cardioprotective effect of rutin a naturally occurring flavonoid
    224. Possible mechanism of Cardioprotective effect of angiotensin preconditioning in isolated rat heart
    225. Mitochondrial KATP channel activation is important in the antiarrhythmic and Cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during …
    226. Cardioprotective effect of probucol in the atherosclerosis-prone JCR: LA-cp rat
    227. Cardioprotective profile of MET‐88, an inhibitor of carnitine synthesis, and insulin during hypoxia in isolated perfused rat hearts
    228. Anti-ischemic effect of a novel Cardioprotective agent, JTV519, is mediated through specific activation of δ-isoform of protein kinase C in rat ventricular myocardium
    229. A possible Cardioprotective effect of heat shock proteins during cardiac surgery in pediatric patients
    230. New 1, 4‐benzothiazepine derivative, K201, demonstrates Cardioprotective effects against sudden cardiac cell death and intracellular calcium blocking action
    231. Cardioprotective effects of red blood cells on ischemia and reperfusion injury in isolated rat heart: release of nitric oxide as a potential mechanism
    232. Cardioprotective mechanisms of ACE inhibition
    233. β Adrenergic receptor desensitisation may serve a Cardioprotective role
    234. A proposed mechanism for the Cardioprotective effect of oestrogen in women: enhanced endothelial nitric oxide release decreases coronary artery reactivity
    235. Caloric restriction restores the Cardioprotective effect of preconditioning in the rat heart
    236. Cardioprotective effect of adenosine pretreatment in coronary artery bypass grafting
    237. The doxorubicin-Cardioprotective drug dexrazoxane undergoes metabolism in the rat to its metal ion-chelating form ADR-925
    238. Cardioprotective effects of carvedilol, a novel β adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol
    239. Cardiac mast cell stabilization and Cardioprotective effect of ischemic preconditioning in isolated rat heart
    240. Why β-blockers are not Cardioprotective in elderly patients with hypertension
    241. Selective activation of E-type prostanoid3-receptors reduces myocardial infarct size: a novel insight into the Cardioprotective effects of prostaglandins
    242. Vasculoprotective and Cardioprotective mechanisms of angiotensin‐converting enzyme inhibition: the homeostatic balance between angiotensin II and nitric oxide
    243. Inhibitory effects of JTV‐519, a novel Cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea‐pig hearts
    244. Role of angiotensin in Cardioprotective effect of ischemic preconditioning
    245. Cardioprotective effect of unstable angina prior to acute anterior myocardial infarction
    246. Cardioprotective potential of carvedilol
    247. Cardioprotective effects of lidoflazine during 1-hour normothermic global ischemia.
    248. Is metformin Cardioprotective?
    249. Cardioprotective activity of endogenous and exogenous nitric oxide on ischaemia reperfusion injury in isolated guinea pig hearts
    250. Free radical generation and the role of allopurinol as a Cardioprotective agent during coronary artery bypass grafting surgery.
    251. Impact of extracellular buffer composition on Cardioprotective efficacy of Na+/H+ exchanger inhibitors
    252. Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction
    253. Cardioprotective potential of angiotensin‐converting enzyme inhibitors
    254. Cardioprotective effects of ischemic preconditioning can be recaptured after they are lost
    255. Effects of CP-060S, a novel Cardioprotective drug, on cardiac function and myocardial oxygen consumption
    256. Clinical perspective on celiprolol: Cardioprotective potential
    257. Mechanism of the Cardioprotective effect of inhibition of the renin-angiotensin system on ischemia/reperfusion-induced myocardial injury
    258. The Cardioprotective effects of moderate alcohol consumption
    259. Cardioprotective effect of α-tocopherol, ascorbate, deferoxamine, and deferiprone: mitochondrial function in cultured, iron-loaded heart cells
    260. How progestins compromise the Cardioprotective effects of estrogens
    261. Antihypertensive and Cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins
    262. Practical Synthesis of Novel Cardioprotective Drug, CP-060S
    263. Cardioprotective actions of an N-terminal fragment of annexin-1 in rat myocardium in vitro
    264. … and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the Cardioprotective action of beta …
    265. Aldose reductase: a novel target for Cardioprotective interventions
    266. The enzymatic hydrolysis-activation of the adriamycin Cardioprotective agent (+)-1, 2-bis (3, 5-dioxopiperazinyl-1-yl) propane.
    267. Cardioprotective and endothelial protective effects of [Ala‐IL8]77 in a rabbit model of myocardial ischaemia and reperfusion
    268. The Cardioprotective role of β‐blockers in patients with diabetes mellitus
    269. Mechanisms of the Cardioprotective effect of a diet enriched with ω-3 polyunsaturated fatty acids
    270. Biochemical changes on the Cardioprotective effect of nicorandil and amlodipine during experimental myocardial infarction in rats
    271. Cardioprotective effect of trimetazidine in severe ischemic cardiomyopathy
    272. Cardioprotective effects of amlodipine in the ischemic-repefused heart
    273. The role of Cardioprotective avoidance beliefs in noncardiac chest pain and associated emergency department utilization
    274. The impact of a Cardioprotective protocol on the incidence of cardiac complications after aortic abdominal surgery
    275. Impact of a novel Cardioprotective agent on the ischaemia-reperfusion-induced Akt kinase activation
    276. Minimally invasive cardiac operation: adapting Cardioprotective strategies
    277. Cardioprotective actions of KC 12291 II. Delaying Na+ overload in ischemia improves cardiac function and energy status in reperfusion
    278. Doxorubicin reduces the iron (III) complexes of the hydrolysis products of the antioxidant Cardioprotective agent dexrazoxane (ICRF-187) and produces hydroxyl …
    279. Hyperalphalipoproteinemia: characterization of a Cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity
    280. Cardioprotective effect of hormone replacement therapy is not due to a selection bias
    281. … action of synthetic oestrogens involves decreased membrane fluidity: relevance to their potential use as anticancer and Cardioprotective agents compared to …
    282. Cardioprotective effects of ibuprofen in experimental regional and global myocardial ischemia
    283. The Cardioprotective effects of a new 1, 4-benzothiazepine derivative, JTV519, on ischemia/reperfusion-induced Ca2+ overload in isolated rat hearts
    284. Cardioprotective actions of KC 12291. I. Inhibition of voltage-gated Na+ channels in ischemia delays myocardial Na+ overload.
    285. Cardioprotective effect of coconut kernel protein in isoproterenol administered rats
    286. The ATP-dependent potassium channel: an endogenous Cardioprotective mechanism.
    287. Inhibition of Na+/H+ exchange at the beginning of reperfusion is Cardioprotective in isolated, beating adult cardiomyocytes
    288. Cardioprotective effects of enalapril in acute myocardial ischemia
    289. PR-39, a proline/arginine-rich antimicrobial peptide, exerts Cardioprotective effects in myocardial ischemia–reperfusion
    290. Cardioprotective effects of captopril in myocardial ischaemia, ischaemia/reperfusion and infarction
    291. Complexation of Ginkgo biloba extract with phosphatidylcholine improves Cardioprotective activity and increases the plasma antioxidant capacity in the rat
    292. Transcription inhibitor actinomycin-D abolishes the Cardioprotective effect of ischemic reconditioning
    293. Comparative antioxidant and Cardioprotective effects of ceruloplasmin, superoxide dismutase and albumin.
    294. Effect of amiloride a Na+/H+ exchange inhibitor on Cardioprotective effect of ischaemic preconditioning: Possible involvement of resident cardiac mast cells
    295. The hydrolysis activation of the doxorubicin Cardioprotective agent ICRF-187 [+)-1, 2-bis (3, 5-dioxopiperazinyl-1-yl) propane).
    296. Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium
    297. Cardioprotective effects of the Na+/H+-exchange inhibitor cariporide in infarct-induced heart failure
    298. Emerging mechanisms for secondary Cardioprotective effects of statins
    299. Mechanisms of the putative Cardioprotective effect of hexamethonium in anesthetized dogs given a large dose of bupivacaine
    300. The role of kinins in the antihypertensive and Cardioprotective effects of ACE inhibitors
    301. What is the Cardioprotective role of hormone replacement therapy?
    302. Role of the Cardioprotective diet in preventing coronary heart disease
    303. Bradykinin-dependent Cardioprotective effects of losartan against ischemia and reperfusion in rat hearts
    304. The Cardioprotective effect of the iron chelator dexrazoxane (ICRF-187) on anthracycline-mediated cardiotoxicity
    305. Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals
    306. The Cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004.
    307. Cardioprotective properties of O-(β-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice
    308. Clinical trial data on the Cardioprotective effects of beta-blockade
    309. Induction of heme oxygenase produces load-independent Cardioprotective effects in hypertensive rats
    310. Cholesterol-lowering drugs as Cardioprotective agents
    311. The Cardioprotective action of quercetin in experimental occlusion and reperfusion of the coronary artery in dogs
    312. Benidipine:A New Ca2+ Channel Blocker with a Cardioprotective Effect
    313. Future Cardioprotective considerations
    314. Resident cardiac mast cells and the Cardioprotective effect of ischemic preconditioning in isolated rat heart
    315. Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart
    316. Cardioprotective effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on cardiac dysfunction induced by ischemia/reperfusion in isolated rat hearts
    317. Mechanisms of in vitro Cardioprotective action of magnesium on the aging myocardium.
    318. Cardioprotective effects of carnitine in extensive aortocoronary bypass grafting: a double-blind, randomized, placebo-controlled clinical trial.
    319. Cardioprotective properties of hydrophilic pollen extract (HPE).
    320. Chronic toxicity and micronucleus assay of the new Cardioprotective agent stobadine in rats.
    321. Dihydroorotase catalyzes the ring opening of the hydrolysis intermediates of the Cardioprotective drug dexrazoxane (ICRF-187)
    322. Intramyocardial injections and protection against myocardial ischemia: an attempt to examine the Cardioprotective actions of adenosine
    323. Aging abolishes the Cardioprotective effect of combination heat shock and hypoxic preconditioning in reperfused rat hearts
    324. Influence of the Cardioprotective agent dexrazoxane on doxorubicin pharmacokinetics in the dog
    325. Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heart
    326. Cardioprotective effects of dihydrolipoic acid and tocopherol in right heart hypertrophy during oxidative stress.
    327. Cardioprotective effect of iron chelators
    328. Magnesium aspartate as a Cardioprotective agent and adjuvant in tocolysis with betamimetics. Animal experiments on the kinetics and calcium antagonist action of …
    329. Effect of ethylisopropyl amiloride, a Na+-H+ exchange inhibitor, on Cardioprotective effect of ischaemic and angiotensin preconditioning
    330. Intensive statin treatment improves baroreflex sensitivity: another Cardioprotective mechanism for statins?
    331. Caveolin-1 peptide exerts Cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism
    332. Down-regulation of Cardioprotective bradykinin type-2 receptors in the left ventricle of patients with end-stage heart failure
    333. Cardioprotective effect of magnesium chloride in experimental acute myocardial infarction
    334. Role of timing of administration in the Cardioprotective effect of fructose-1, 6-bisphosphate
    335. Ferrous ion strongly promotes the ring opening of the hydrolysis intermediates of the antioxidant Cardioprotective agent dexrazoxane (ICRF-187)
    336. Randomized, controlled trial of antioxidant vitamins and Cardioprotective diet on hyperlipidemia, oxidative stress, and development of experimental atherosclerosis …
    337. Platelet-derived adenosine contributes to the Cardioprotective effects of platelets against ischemia-reperfusion injury in isolated rat heart.
    338. Relative plasma levels of the Cardioprotective drug dexrazoxane and its two active ring-opened metabolites in the rat
    339. Cardioprotective effects of recombinant human extracellular-superoxide dismutase type C in rat isolated heart subjected to ischemia and reperfusion.
    340. Cardioprotective actions of transforming growth factor-β
    341. Synthesis and biological studies of a new ginkgolide C derivative: evidence that the Cardioprotective effect of ginkgolides is unrelated to PAF inhibition
    342. Cardioprotective effects of mioflazine during 1 h normothermic global ischaemia in the canine heart
    343. Cardioprotective potential of antihypertensives
    344. Wortmannin, a potent antineutrophil agent, exerts Cardioprotective effects in myocardial ischemia/reperfusion
    345. Cardioprotective effect of MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one) during acute ischemia-reperfusion injury in rats
    346. Help from within: Cardioprotective properties of hepatocyte growth factor
    347. … spin traps and their pyrrolidine analogs in myocardial reperfusion injury: hemodynamic and ESR implications: Evidence for a Cardioprotective phosphonate effect for 5 …
    348. Cardioprotective efficacy of verapamil and mibefradil in young UM-X7. 1 cardiomyopathic hamsters
    349. The Cardioprotective action of 18-dehydroglycyrrhetic acid in experimental myocardial damage
    350. Cardioprotective actions of potassium channel openers
    351. Cardioprotective actions of specific thromboxane receptor antagonist in acute myocardial ischemia.
    352. Cardioprotective effects of nucleoside transport inhibition in rabbit hearts
    353. Acute brain death abolishes the Cardioprotective effects of ischemic preconditioning in the rabbit
    354. Lack of Cardioprotective effect of naproxen
    355. Cardioprotective effects of abciximab (ReoPro (R)) in an isolated perfused rat heart model of ischemia and reperfusion
    356. Cardioprotective effect of pump prime aprotinin in coronary artery bypass grafting
    357. Cardioprotective effects of ovarian hormones and the HERS in perspective
    358. New concepts in the Cardioprotective action of magnesium and taurine during the calcium paradox and ischaemia of the heart.
    359. Cardioprotective effects of alcohol: mediation by human vascular alcohol dehydrogenase
    360. Cardioprotective effects of ACE inhibitors: experimental proof and clinical perspectives.
    361. Cardioprotective effects of hexasulfobutylated C60 (FC4S) in anesthetized rats during coronary occlusion/reperfusion injury
    362. Cardioprotective effect of desferrioxamine
    363. The Cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane (ICRF-187) antagonizes camptothecin-mediated growth inhibition of Chinese hamster …
    364. Cardioprotective effect of L-arginine in myocardial ischemia and reperfusion in an isolated working rat heart model
    365. Quantification of Cardioprotective gene expression in porcine short-term hibernating myocardium
    366. Opiatergic mechanisms of Cardioprotective and antiarrhythmic effects of adaptation
    367. Cardioprotective effect of angiotensin II receptor antagonists.
    368. Cardiovascular actions in vitro and Cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist.
    369. Cardioprotective effects of the aminopeptidase P inhibitor apstatin: studies on ischemia/reperfusion injury in the isolated rat heart
    370. Norepinephrine release after acute brain death abolishes the Cardioprotective effects of ischemic preconditioning in rabbit
    371. Characterization of sabiporide, a new specific NHE-1 inhibitor exhibiting slow dissociation kinetics and Cardioprotective effects
    372. Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits
    373. Failure of aspirin to interfere with the Cardioprotective effects of ifetroban
    374. Cardioprotective effects of defibrotide in acute myocardial ischemia in the cat
    375. Do endogenous ligands of peripheral μ-and δ-opiate receptors mediate antiarrhythmic and Cardioprotective effects of Rhodiola rosea?
    376. Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease
    377. Comparison of Cardioprotective efficacy of two thromboxane A2 receptor antagonists
    378. Adaptogenic and Cardioprotective Action of Galleria mellonella Extract in Rats and Frogs
    379. Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours
    380. Myocardial glycogen depletion cannot explain the Cardioprotective effects of ischemic preconditioning in the rat heart
    381. The removal of metal ions from transferrin, ferritin and ceruloplasmin by the Cardioprotective agent ICRF-187 [(+)-1, 2-bis (3, 5-dioxopiperazinyl-1-yl) propane] and its …
    382. Cardioprotective Effect of Propranolol From Alcohol‐Induced Heart Muscle Damage as Assessed by Plasma Cardiac Troponin‐T
    383. Is hepatocyte growth factor a protein with Cardioprotective activity in the ischemic heart?
    384. Efficacy of dexrazoxane as a Cardioprotective agent in patients receiving mitoxantrone-and daunorubicin-based chemotherapy.
    385. Perspectives on the Cardioprotective effects of statins
    386. … tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the Cardioprotective action of tamoxifen?
    387. Mechanisms of the Cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion.
    388. Synthesis, vasodilating, antithrombotic and Cardioprotective activity of pyridyl substituted 5-silyl (germyl) isoxazolines-2
    389. Iron complexes of the Cardioprotective agent dexrazoxane (ICRF-187) and its desmethyl derivative, ICRF-154: solid state structure, solution thermodynamics, and DNA …
    390. Measurement of Troponin T and I to detect Cardioprotective effect of aminophylline during coronary artery bypass grafting
    391. Cardioprotective effects of platelets against ischaemia-reperfusion injury are related in part to platelet glutathione redox cycle
    392. N-oxygenation of stobadine, a γ-carboline antiarrhythmic and Cardioprotective agent: The role of flavin-containing monooxygenase
    393. Cardioprotective effect and influence on NOS expression of Montelukast sodium in rats
    394. Differences in Cardioprotective efficacy of adrenergic receptor antagonists and Ca2+ channel antagonists in an animal model of dilated cardiomyopathy. Effects on …
    395. Clinical implications for therapy: possible Cardioprotective effects of ACE inhibition.
    396. Carvedilol: an effective antihypertensive drug with antiischemic/antioxidant Cardioprotective properties
    397. Cardioprotective effects of melatonin on recovery of rat donor hearts after 12-hour preservation
    398. Close correlation of the Cardioprotective effect of FK409, a spontaneous NO releaser, with an increase in plasma cyclic GMP level
    399. Has melatonin a future as a Cardioprotective agent?
    400. Cardioprotective effects of lazaroid U-74389G on ischemia-reperfusion injury in canine hearts
    401. Development of the Na+/H+ exchange inhibitor cariporide as a Cardioprotective drug: from the laboratory to the GUARDIAN trial
    402. Glyburide-reversible Cardioprotective effects of calcium-independent phospholipase A2 inhibition in ischemic rat hearts
    403. Cardioprotective action of alpha-blocking agents, phentolamine and bunazosin, on hypoxic and reoxygenated myocardium.
    404. Cardioprotective effects of chronic hypoxia: relation to preconditioning
    405. Cardioprotective effects of Na+/H+ exchange inhibitors
    406. Protein kinase C is involved in Cardioprotective effects of ischemic preconditioning on infarct size and ventricular arrhythmia in rats in vivo
    407. New intraoperative Cardioprotective strategies for myocardial protection.
    408. JTV-519, a novel Cardioprotective agent, improves the contractile recovery after ischaemia-reperfusion in coronary perfused guinea-pig ventricular muscles
    409. Adenosine deaminase inhibition is not Cardioprotective in the rat
    410. Gender differences in the effect of genistein on vascular smooth muscle cells: a possible Cardioprotective effect?
    411. The role of the prostaglandin system in the Cardioprotective effect of adaptation to hypoxia in stress
    412. Cardioprotective effect of IGF-1 in mouse with adriamycin induced cardiomyopathy
    413. Inotropic effect of the Cardioprotective agent 2, 3-butanedione monoxime in failing and nonfailing human myocardium.
    414. Repetitive preischemic infusion of phosphodiesterase III inhibitor olprinone elicits Cardioprotective effects in the failing heart after myocardial infarction
    415. Cardioprotective effects of quinapril after myocardial infarction in hypertensive rats
    416. Cardioprotective effects of N‐hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats
    417. Cardioprotective effects of various class I antiarrhythmic drugs in canine hearts
    418. Cardioprotective action of sodium gamma-hydroxybutyrate against isoproterenol induced myocardial damage.
    419. Cardioprotective effects of NIP-121, a novel ATP-sensitive potassium channel opener, during ischemia and reperfusion in coronary perfused guinea pig myocardium
    420. Cardioprotective EFFECTS OF THE LAZAROID U74389G FOLLOWING COLD PRESERVATION AND TRANSPLANTATION OF RAT HEARTS1
    421. The iron (III) and copper (II) complexes of adriamycin promote the hydrolysis of the Cardioprotective agent ICRF-187 ((+)-1, 2-bis (3, 5-dioxopiperazinyl-1-yl) propane)
    422. Loss of Cardioprotective effects of preinfarction angina in elderly but not in adult patients
    423. Cardioprotective effect of trimetazidine during thrombolytic therapy in patients with acute myocardial infarction
    424. The Cardioprotective effect of verapamil.
    425. Scavenging of Hypochlorous Acid and the Myoglobin-Derived Oxidants By of Cardioprotective Agent Mercaptopropionylglycine
    426. The Cardioprotective effect of γ‐glutamylcysteine ethyl ester during coronary reperfusion in canine hearts
    427. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat
    428. Effects of CP‐060S, a novel Cardioprotective drug, in the methacholine‐induced ECG change model in rats
    429. Cardioprotective Effect of Mexiletine in Acute Myocardial Ischemia Studies in the Rabbit Closed Chest Ischemia Model
    430. Cardioprotective effect of moderate drinking: possible mediation by vital exhaustion
    431. Sodium-hydrogen exchange inhibition—superior Cardioprotective strategy
    432. Influence of Cardioprotective cyclooxygenase and lipoxygenase inhibitors on peroxidative injury to myocardial-membrane phospholipid
    433. Beta‐blockers and thoracic epidural analgesia. Cardioprotective and synergistic effects
    434. Are calcium antagonists Cardioprotective?
    435. Is hormone replacement therapy Cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
    436. Antagonizing bradykinin (BK) obliterates the Cardioprotective effects of bradykinin and angiotensin‐converting enzyme (ACE) Inhibitors in ischemic hearts
    437. Involvement of free radicals in the Cardioprotective effect of defibrotide.
    438. Cardioprotective EFFECTS OF PINACIDIL PRETREATMENT AND LAZAROID (U74500A) PRESERVATION IN ISOLATED RAT HEARTS AFTER 12-HOUR …
    439. Preischemic and postischemic treatment with a new Na+/H+-exchange inhibitor, FR183998, shows Cardioprotective effects in rats with cardiac ischemia and …
    440. Cardioprotective actions of human superoxide dismutase in two reperfusion models of myocardial ischaemia in the rat.
    441. Glyburide-reversible Cardioprotective effects of BMS-180448: functional and energetic considerations
    442. Cardioprotective actions of pentoxifylline in an animal model of acute myocardial ischaemia.
    443. Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophy.
    444. for the Cardioprotective and Therapeutic Role of Creatine Phosphate
    445. A novel Cardioprotective agent, JTV-519, is abolished by nitric oxide synthase inhibitor on myocardial metabolism in ischemia-reperfused rabbit hearts
    446. Biotransformation of stobadine, a γ-carboline antiarrhythmic and Cardioprotective agent, in rat liver microsomes
    447. Cardioprotective effect of trimetazidine and nifedipine in guinea-pig hearts subjected to ischaemia.
    448. Cardioprotective Effects Of Nicorandil In Rabbits Anaesthetized With Halothane: Potentiation Of Ischaemic Preconditioning Via KATP Channels
    449. Participation of calcium ions in the molecular mechanism of Cardioprotective action of exogenous phosphocreatine
    450. Cardioprotective effect of d-propranolol in ischemic-reperfused isolated rat hearts
    451. Cardioprotective and antidysrhythmic effects of alpha 1-adrenoceptor blockade during myocardial ischaemia and reperfusion in the dog.
    452. Heart preservation: analysis of Cardioprotective infusate characteristics. Membrane stabilization, calcium antagonism, and protease inhibition on myocardial viability: a …
    453. Diadenosine tetraphosphate (AP4A) mimics Cardioprotective effect of ischemic preconditioning in the rat heart: contribution of KATP channel and PKC
    454. The role of ITP-DAG regulatory cascade in the mechanism of Cardioprotective effect of adaptation to stress.
    455. A comparative evaluation of the Cardioprotective and antianginal actions of energy-providing agents
    456. Does treatment-mediated increase in uric acid reduce the Cardioprotective effects of diuretics in hypertensive patients?
    457. Cardioprotective effects of thiazolidinediones, peroxisome proliferator-activated receptor-gamma agonists
    458. Studies on the signal cascade mechanism mediating the Cardioprotective actions of bradykinin.
    459. Role of phospholipases in myocardial ischemia: effect of Cardioprotective agents on the phospholipases A of heart cytosol and sarcoplasmic reticulum in vitro
    460. Cardioprotective aspects of calcium antagonists.
    461. Cardiotrophin‐1 (CT‐1): a novel hypertrophic and Cardioprotective agent
    462. Underuse of Cardioprotective medications in patients prior to acute myocardial infarction
    463. 31P-NMR spectroscopic investigations and mitochondrial studies on the Cardioprotective efficiency of 2-mercartopropionylglycine
    464. Activation of the adenosine triphosphate sensitive mitochondrial potassium channel is involved in the Cardioprotective effect of isoflurane
    465. Insights into the Cardioprotective function of adenosine A1 and A3 receptors
    466. The Cardioprotective effects of Na+/H+ exchange inhibition and mitochondrial K ATP channel activation are additive in the isolated rat heart
    467. Binding of ATP-Sensitive Potassium Channel (KATP) Openers to Cardiac Membranes:  Correlation of Binding Affinities with Cardioprotective and Smooth Muscle …
    468. Cardioprotective effects of amlodipine on ischemia and reperfusion in two experimental models
    469. The antihypertensive and Cardioprotective effects of (−)-MJ-451, an ATP-sensitive K+ channel opener
    470. Cardioprotective actions of oligotide, a single stranded polydeoxyribonucleotide complex, in myocardial ischaemia and reperfusion injury.
    471. Cardioprotective effects of adaptogens of plant origin
    472. Cardioprotective EFFECT OF NICORANDIL IN HISTIDINE-TRYPTOPHAN-KETOGLURATE SOLUTION DURING THE COLD STORAGE OF ISOLATED …
    473. Beta-adrenergic blockers as Cardioprotective agents
    474. Cardioprotective effects of phosphocreatine in vascular surgery
    475. Cardioprotective effects of KR-30450, a novel K+ ATP opener, and its major metabolite KR-30818 on isolated rat hearts
    476. Contribution of bradykinin to the Cardioprotective action of angiotensin converting enzyme inhibition in hypertension and after myocardial infarction
    477. Studies of the Cardioprotective effects of ascorbic acid in isolated rabbit hearts.
    478. Metal ion-promoted hydrolysis of the antioxidant Cardioprotective agent dexrazoxane (ICRF-187) and its one-ring open hydrolysis products to its metal-chelating active …
    479. Cardioprotective potency of the radical scavenger S-2-(3 aminopropylamino) ethylphosphorothioic acid in the post-ischaemic rat heart
    480. Enzymatic ring-opening reactions of the chiral Cardioprotective agent (+)(S)-ICRF-187 and its (-)(R)-enantiomer ICRF-186 by dihydropyrimidine amidohydrolase …
    481. Cardioprotective effect of prostacyclin and 7-oxo-PGI2 in rats against chronic isoproterenol damage
    482. Role of timing of administration in the Cardioprotective effect of iloprost, a stable prostacyclln mimetic
    483. The Cardioprotective effects of R 75231 and lidoflazine are not caused by adenosine A1 receptor activation.
    484. Heparinase III exerts endothelial and Cardioprotective effects in feline myocardial ischemia-reperfusion injury
    485. Effect of timing of treatment of the glyburide-reversible Cardioprotective activity of BMS-180448
    486. Cardioprotective therapeutics–drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants.
    487. Evaluation of the safety and Cardioprotective effects of eniporide, a specific Sodium/Hydrogen exchange inhibitor, given as adjunctive therapy to reperfusion in …
    488. Involvement of endogenous opioids in Cardioprotective effects of ischemic preconditioning in the isolated rat heart
    489. Evidence for Cardioprotective, renoprotective, and vasculoprotective effects of vasopeptidase inhibitors in disease
    490. A New Year toast… to the Cardioprotective effects of alcohol.
    491. The antiacidotic and Cardioprotective effects of fructose-1, 6-diphosphate and dehydroascorbic acid
    492. Cardioprotective effect of diadenosine tetraphosphate (AP4A) preservation in hypothermic storage and its relation with mitochondrial ATP-sensitive potassium …
    493. CP-060S, a novel Cardioprotective drug, limits myocardial infarct size in anesthetized dogs
    494. Cardioprotective effects of a new vascular intracellular calcium antagonist, KT-362, in the stunned myocardium.
    495. Cardioprotective actions of adenosine and adenosine analogs
    496. Can inhibition of the renin-angiotensin system have a Cardioprotective effect?
    497. The characteristics of the Cardioprotective action of fructose-1, 6-diphosphate
    498. Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation
    499. Increased activity of sarcolemmal (Na+ K+)-ATPase is involved in the late Cardioprotective action of 7-oxo-prostacyclin.
    500. Effect of a novel Cardioprotective agent, JTV-519, on metabolism, contraction and relaxation in the ischemia-reperfused rabbit heart
    501. Comparative Cardioprotective effects of cromakalim and diltiazem in ischemic hypertrophied rat hearts
    502. Na+-H+ exchange inhibition at reperfusion is Cardioprotective during myocardial ischemia reperfusion; 31P NMR studies
    503. Cardioprotective action of the new stable epoprostenol analogue CG 4203 in rat models of cardiac hypoxia and ischemia.
    504. Pharmacokinetics and biological fate of 3-(2, 2, 2-trimethylhydrazinium) propionate dihydrate (MET-88), a novel Cardioprotective agent, in rats
    505. Cardioprotective and hypolipidemic effects of nisoldipine in the JCR: LA-cp rat
    506. Diet and coronary heart disease: advice on a Cardioprotective diet
    507. Plasma concentration, tissue distribution and excretion of the prospective Cardioprotective agent cis-(-)-2, 3, 4, 4a, 5, 9b-hexahydro-2, 8-dimethyl-1H-pyrido-[4, 3-b] …
    508. Participation of inducible stress-proteins in realizing the Cardioprotective effect of Rhodiolae rosea
    509. Cardioprotective effects of an early invasive strategy for non–ST-segment elevationacute coronary syndromes: Are we all becoming “interventional” …
    510. Cardioprotective effects of amlodipine in animal models of ischemia and reperfusion.
    511. Effect of the Cardioprotective agent stobadine on reproduction in rats.
    512. Cardioprotective efficiency of dihydrolipoic acid in working rat hearts during hypoxia and reoxygenation. 31P nuclear magnetic resonance investigations.
    513. Time dependence of the Cardioprotective effects of lercanidipine
    514. Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia.
    515. Protein kinase inhibition exerts Cardioprotective effects in myocardial ischemia/reperfusion via inhibition of superoxide release.
    516. KATP‐channel activation: effects on myocardial recovery from ischaemia and role in the Cardioprotective response to adenosine A1‐receptor stimulation
    517. Cardioprotective Actions by a Water-Soluble Carbon Monoxide-Releasing Molecule: UltraRapid Communications
    518. New perspectives on the Cardioprotective phosphonate effect of the spin trap 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide: an hemodynamic and 31P NMR …
    519. Role of bradykinin in the antihypertensive and Cardioprotective actions of converting enzyme inhibitors
    520. The Cardioprotective action of carnitine and its structural analog 3-(2, 2, 2-trimethylhydrazine) propionate on cardiac energy metabolism in experimental occlusion of …
    521. Angiotensin-converting enzyme inhibitors as Cardioprotective agents
    522. The one-ring open hydrolysis intermediates of the Cardioprotective agent dexrazoxane (ICRF-187) do not inhibit the growth of Chinese hamster ovary cells or the …
    523. Cardioprotective effects of 9-hydroxyellipticine on ischemia and reperfusion in isolated rat heart
    524. Metabolism of the Cardioprotective agents dexrazoxane (ICRF-187) and levrazoxane (ICRF-186) by the isolated hepatocyte
    525. Cardioprotective effects of amlodipine in the ischemic-reperfused heart
    526. … , a new Na+/H+ exchange inhibitor, on ischemia and reperfusion-induced arrhythmia and myocardial infarction in rats: in comparison with other Cardioprotective …
    527. Cardioprotective properties of olive oil-derived polyphenols
    528. Electrophysiologic, antiarrhythmic, and Cardioprotective effects of N-[3, 5 dichlorophenyl] 4-[4-hydroxy-2-methoxy-phenyl] piperazine carboxamidine dihydrochloride …
    529. Cardioprotective effects of diltiazem when given before, during or delayed after infusion of norepinephrine in anesthetized dogs
    530. Cardioprotective effect of the glycogen phosphorylase inhibitor CP-380867
    531. Cardioprotective effect against ischemia-reperfusion injury of AHC-52, a dihydropyridine compound with inhibitory effect on Cl–but not Ca2+ current
    532. Cardioprotective effect of alcohol consumption: contemporary concepts
    533. Cardioprotective actions of a new calcium channel blocker in acute myocardial ischemia.
    534. Studies of hypoxemic/reoxygenation injury: With aortic clamping: X. Exogenous antioxidants to avoid nullification of the Cardioprotective effects of blood …
    535. The Cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin
    536. Cardioprotective and antioxidant effects of apomorphine
    537. Cardioprotective effects of diltiazem during acute rejection on heterotopic heart transplants
    538. Cardioprotective effects of an angiotensin-converting-enzyme inhibitor, imidapril, and Ca2+ channel antagonist, amlodipine, in spontaneously hypertensive rats at …
    539. Platelet-mediated Cardioprotective effect against ischemia-reperfusion injury in isolated rat hearts: role of platelet number and contribution of supernatant of …
    540. Adaptation of the heart to ischemia by preconditioning: Effects on energy equilibrium properties of sarcolemmal ATPases and release of Cardioprotective proteins
    541. A comparison of the Cardioprotective effects of calcium antagonists from different classes upon ischaemic damage in the guinea-pig working heart
    542. Cardioprotective effects of beraprost sodium against experimental ischemia and reperfusion as compared with propranolol and diltiazem.
    543. Advances in myocardial protection: The role of mechanical devices in providing Cardioprotective strategies
    544. Invited Review: Cardioprotective Effects of ω‐3 Fatty Acids
    545. Chemical stability of the Cardioprotective agent ICRF-187 in infusion fluids
    546. Unique Cardioprotective potential of angiotensin converting enzyme inhibitors: a hypothesis still to be tested on humans.
    547. Cardioprotective Actions of Verapamil on theβ-Adrenergic Receptor Complex in Acute Canine Chagas’ Disease
    548. Cardioprotective effect of taurine
    549. Do kinins mediate Cardioprotective and renoprotective effects of cilazapril in spontaneously hypertensive rats with renal ablation?
    550. Cardioprotective effect of heme oxygenase-1 induction by hemin on the isolated rat heart during ischemia–reperfusion
    551. Is the apparent Cardioprotective effect of recent alcohol consumption due to confounding by prodromal symptoms?
    552. Comparison of the Cardioprotective efficacy of superoxide dismutase in a single and a repetitive coronary occlusion model in rabbit hearts.
    553. Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and Cardioprotective effects in the canine myocardium
    554. Cardioprotective actions of nisoldipine in postreperfusion myocardial ischemia
    555. In vitro micronucleus test of the Cardioprotective agent stobadine. A genotoxicological study.
    556. Cardioprotective effect of bradykinin-induced preconditioning mediated by calcitonin gene-related peptide in isolated rat heart.
    557. Cardioprotective effect of exogenous phosphocreatine in patients undergoing open heart surgery
    558. Novel Cardioprotective effects of TYB-3823 on ischemic damage in the working hearts of rats: comparison with lidocaine.
    559. Effect of actinomycin D and cycloheximide on ischemic preconditioning induced delayed Cardioprotective effect in rats
    560. Effect of ibuprofen on Cardioprotective effect of aspirin
    561. Hydroxyl radical production by the iron complex of the hydrolysis product of the antioxidant Cardioprotective agent ICRF-187 (dexrazoxane)
    562. Cardioprotective properties of a 1, 4-dihydropyridine derivative, glutapyrone, in deep hypothermia
    563. Cardioprotective effects of defibrotide in acute lethal and nonlethal myocardial ischemia in the cat
    564. Cardioprotective efficacy of ischemic preconditioning on long-term myocardial ischemia
    565. Mechanisms of vasoinhibitory effect of Cardioprotective agent, CP-060S, in rat aorta
    566. Cardioprotective effect of pindolol in ischemic-reperfused isolated rat hearts
    567. Significance of the Cardioprotective effect of prostanoids and indomethacin.
    568. … )-N-(1H-imidazol-2-ylmethyl) dimethyl-2H-1-benzopyran-6-carbonitril monohydrochloride (BMS-191095): Cardioprotective, hemodynamic, and electrophysiological …
    569. Synthesis of tritium‐labelled stobadine, a new Cardioprotective agent
    570. Cardioprotective effects of adaptation to restraint stress and hypoxia
    571. Heterogeneity of myocardial edema in isolated pig hearts after perfusion with different types of Cardioprotective solutions
    572. Calcium antagonists as Cardioprotective agents
    573. A Cardioprotective approach to the management of hypertension.
    574. Participation of inducible stress proteins in the Cardioprotective effect of Rhodiolae rosea
    575. Cardioprotective effects of diltiazem infusion in the perioperative period in patients undergoing coronary artery bypass grafting with extracorporeal circulation
    576. Mitochondrial sulfhydryl groups under oligomycin-inhibited, aging, and uncoupling conditions: Beneficial influence of Cardioprotective drugs
    577. Cardioprotective effect of cromakalim (potassium channel opener) in isoproterenol induced myocardial infarction in rats.
    578. Zinc as a Cardioprotective antioxidant
    579. Cardioprotective effects of sodium gamma-hydroxybutyrate (GHB) on brain induced myocardial injury.
    580. Cardioprotective effect of L-carnitine in rats submitted to permanent left coronary artery ligation
    581. Captopril and L-arginine have a synergistic Cardioprotective effect in ischemic-reperfusion injury in the isolated rat heart
    582. The Cardioprotective actions of iloprost in myocardial ischemia of the rabbit can be separated from its vasodilatory effects mediated by KATP (+)-channel opening.
    583. Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: Role of angiotensin II type 2 receptor
    584. The displacement of iron (III) from its complexes with the anticancer drugs piroxantrone and losoxantrone by the hydrolyzed form of the Cardioprotective agent …
    585. Hydrogen Peroxide-Dependent Liver Microsomal N-Demethylation and N-Oxygenation of Stobadine, a γ-Carboline Antiarrhythmic and Cardioprotective Agent
    586. Statins as Cardioprotective agents
    587. Cardioprotective effect of enantiomers of cicletanine (BN50417, BN50418) in ischaemic/reperfused isolated working rat hearts: interaction with glibenclamide
    588. Mechanism for the Cardioprotective effects of the calcium channel blocker clentiazem during ischemia and reperfusion
    589. … to vascular cell adhesion molecule‐1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative Cardioprotective role of TGF‐β1 …
    590. Ecto-5′-nucleotidase plays a role in the Cardioprotective effects of heat shock protein 72 in ischemia–reperfusion injury in rat hearts
    591. Differential action of KR‐31378, a novel potassium channel activator, on Cardioprotective and hemodynamic effects
    592. Cardioprotective effects of nicorandil on calcium paradox‐induced injury
    593. SM-20550, a new Na+/H+ exchange inhibitor and its Cardioprotective effect in ischemic/reperfused isolated rat hearts by preventing Ca2+-overload
    594. A possible acetaldehyde-mediated Cardioprotective mechanism
    595. Cardioprotective effects of postmenopausal hormone treatment
    596. Differential Cardioprotective properties of the l-and d-enantiomers of bucindolol in a canine model of heart failure.
    597. Adenosine A1 receptor blockade does not abolish the Cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalim
    598. Comparison of the Cardioprotective effects of nitroglycerin, molsidomine, and SIN-1 in rats
    599. Cardioprotective effects of SF pretreatment mediated by bradykinin on isolated rat heart
    600. Electrocardiographic evidence for a Cardioprotective effect of nifedipine during experimental hypercalcemia
    601. Cardioprotective effects by ramipril after ischemia and reperfusion in animal experiment studies
    602. Experimental approaches to determining molecular mechanisms of antiarrhythmic and Cardioprotective actions of new compounds
    603. Cariporide is Cardioprotective after iatrogenic ventricular fibrillation in the intact swine heart
    604. Cardioprotective drugs decrease the Na+ background current
    605. Effect of ibuprofen on Cardioprotective effect of aspirin
    606. The use of the new Cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients
    607. Cardioprotective effect of the ischemic preconditioning: its relation to activation of protein kinase C
    608. Cardioprotective effect of a novel cyclohexane dicarboximide derivative, ST‐6, against ischemia/reperfusion injury
    609. Cardioprotective effects of adenosine transport inhibition during reversible ischaemia in patients with coronary artery disease
    610. Pharmacological characterization of AMP 579, a novel adenosine A1/A2 receptor agonist and Cardioprotective
    611. The evolution of a Cardioprotective antimetastatic and antitumor drug: An international adventure
    612. Hormone replacement therapy Cardioprotective effect is genuine
    613. Effect of ibuprofen on Cardioprotective effect of aspirin
    614. The Cardioprotective effect of ischemic preconditioning: Role of adenosine and protein kinase C
    615. Dexrazoxane: a new Cardioprotective agent
    616. Cardioprotective and antiarrhythmic effects of β-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia
    617. Cardioprotective effect of enalapril in renovascular and angiotensin II hypertension
    618. Cardiodepressive Effects of Mercurial Diuretics. Cardioprotective Value of BAL, Ascorbic Acid and Thiamin.
    619. Cardioprotective effect of diadenosine tetraphosphate (AP4A) cardioplegia in isolated rat hearts
    620. Is esmolol Cardioprotective? Tolerance of pacing tachycardia, acute afterloading and hemodilution in dogs with coronary stenosis
    621. Gardiodepressive Effects of Thiomerin: Cardioprotective Attempts with BAL, Ascorbic Acid and Thiamin
    622. Role or RAS changes in overtrained myocardial injury in rats and Cardioprotective effect or Captopril [J]
    623. Cardioprotective effects of selenium and morin hydrate in a murine model of chronic iron overload
    624. Cardioprotective effects of Iloprost
    625. High performance liquid chromatographic analysis of the Cardioprotective agent dexrazoxane in human plasma and urine
    626. Cardioprotective effect of glycyram in myocardial damage induced by isadrine
    627. Cardioprotective effects of acutely administered ramipril and losartan on myocardial infarct size in cholesterol-fed and salt-fed rats
    628. Myocardial ischemia-reperfusion injury and the Cardioprotective potential of natural antioxidants
    629. Cardioprotective effect of carnitine and its synthetic analog 3-(2, 2, 2-trimethylhydrazinium) propionate in rats with experimental myocardial infarction
    630. Cardioprotective effect of Vitamin E in doxorubicin induced acute cardiotoxicity in Rats
    631. Cardioprotective effects of preinfarction angina in elderly: same patients, different results?
    632. Cardioprotective effects of T3-146, a cyclic derivative of γ-aminobutyric acid, under conditions of reperfusion
    633. BMS-180448, a novel glyburide-reversible Cardioprotective agent, enhances postischemic recovery of contractile function in dogs.
    634. Cardioprotective effects of stimulation of peripheral μ-opiate receptors and the role of opiatergic mechanisms in the pathogenesis of stress-induced heart damage
    635. Potential Cardioprotective effect of mibefradil in the long-term treatment of hypertension
    636. The novel Cardioprotective agent BMS-180448 activates a potassium conductance in cardiac and vascular smooth muscle
    637. Cardioprotective actions of enalapril and lisinopril on ischemia-reperfusion induced myocardial infarction in normal and salt loaded rats
    638. Comparative analysis of the Cardioprotective effect of antioxidant dibunol and agonists of mu-and delta-opioid receptors during oxidative stress
    639. Cardioprotective effects of aspirin compromised by other NSAIDs
    640. Participation of K (ATP)-channels in Cardioprotective effect of mu-opioid receptor agonists in acute ischemia and reperfusion of the isolated heart
    641. Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the rat.
    642. Cardioprotective nutrients in walnuts
    643. Cardioprotective effects of intracerebroventricular morphine postconditioning against ischemia-reperfusion injury in rat heart
    644. Cardioprotective potential of angiotensin converting enzyme inhibitors.
    645. The Cardioprotective Efficacy of TMZ During Coronary Artery Bypass Graft Surgery [J]
    646. Injection Preparation of Dan-shen (Salvia miltiorrhiza) Enhances the Cardioprotective Effects of Ischemic Preconditioning in Rat [J]
    647. Cardioprotective therapeutics–drugs used in hypertension, hyperlipidaemia, thromboembolization, arrhythmias, postmenopausal state and as anti-oxidants.
    648. Cardioprotective effect of cromakalim, a K+ channel opener, on isolated globally ischemic and reperfused rat hearts
    649. Are transdermic estrogens Cardioprotective?
    650. Cardioprotective effects of YM934, an ATP-sensitive potassium channel opener, on stunned myocardium in anesthetized dogs
    651. Permissive effect of molsidomine towards Cardioprotective action of iloprost in myocardial ischaemia in cats
    652. Possible involvement of endothelin-1 in Cardioprotective effects of benidipine
    653. AHC‐52, a Dihydropyridine Compound with Chloride Current Blocking and Cardioprotective Activities
    654. Cardioprotective Effects of Cyclovirobuxine D on the Myocardial Infarction in Anesthetized Dogs
    655. The antiarrhythmic and Cardioprotective effects of non-hypotensive doses of nicorandil and celikalim during ischemia/reperfusion in anesthetized rabbits is due to …
    656. Evaluation of Cardioprotective effects of DelNido cardioplegia
    657. Cardioprotective effect of matrine on myocardial ischemia in hypercholesterolemia rats
    658. Beta‐blockers in heart failure—a Cardioprotective therapy?
    659. DOSE‐INDEPENDENT PHARMACOKINETICS OF THE Cardioprotective AGENT DEXRAZOXANE IN DOGS
    660. Role of the Inositol Phosphate Cycle in the Cardioprotective Effect of Adaptation to Intermittent Hypoxia
    661. Cardioprotective effect of taurine on calcium paradox in streptozotocin-induced diabetic rat hearts
    662. The doxorubicin Cardioprotective agent dexrazoxane (ICRF-187) induces endopolyploidy in rat neonatal myocytes through inhibition of DNA topoisomerase II
    663. Possible role of nitric oxide in the Cardioprotective actions of enalapril and lisinopril in rats
    664. Cardioprotective effects of hydrolyzed bopindolol against contractile dysfunction produced by coronary stenosis and reperfusion in dogs.
    665. Cardioprotective effect of K-7259, a novel dilazep derivative, against ischemia-reperfusion damage in isolated, working rat hearts
    666. Cardioprotective benefits of hormone replacement therapy
    667. Acadesine: a unique Cardioprotective agent for myocardial ischemia.
    668. A novel Cardioprotective regimen for improvement of inner mitochondrial membrane function after ischemic stress.
    669. The contribution of antioxidant enzymes in the Cardioprotective effect of opioids during oxidative stress
    670. Cardioprotective properties of some synthetic antioxidants
    671. Cardioprotective and antiapoptotic effects of aminoguanidine
    672. Cardioprotective effect of orally administered angiotensin-converting enzyme inhibitor against ischemia
    673. Effect of Cardioprotective drugs on cardiomyopathic hamster J-2-N
    674. Naproxen’s interaction with aspirin may affect its Cardioprotective effect
    675. Cardioprotective effect of angina within 48 hours before acute myocardial infarction in the aged [J]
    676. Involvement of adenosine in Cardioprotective effect of catecholamine preconditioning in ischemia-reperfused heart of rat
    677. The Cardioprotective Role of HRT: A Clinical Update
    678. Mechanisms of Cardioprotective effects of propranolol against reperfusion injury
    679. Cardioprotective effects of carbocromen in awake and anesthetized dogs with amitriptyline poisoning.
    680. R 56865 exerts Cardioprotective properties independent of the intracellular Na+-overload in the guinea pig heart
    681. Cardioprotective effect of metipranolol on ischemic heart muscle
    682. Cardioprotective effects of nicorandil in MIDCAB patients
    683. Cardioprotective effects of nicorandil on isoproterenol‐induced injury
    684. Cardioprotective effect of bepridil on ischemic myocardial damages in dogs.
    685. Identification of a new Cardioprotective agent—6 (2‐isopropylaminopropyl)‐3‐pyridinol
    686. Effect of ibuprofen on Cardioprotective effect of aspirin
    687. Antistress and Cardioprotective properties of the synthetic analog of endogenous opioids dalargin in experimental burn trauma in rats
    688. Automatic quantification of the effect of Cardioprotective drugs in isolated myocytes
    689. Cardioprotective effect of levcromakalim in isolated guinea pig heart preparations
    690. Cardioprotective effect of ischemic preconditioning on global myocardial ischemia in a sheep right heart bypass model
    691. The Cardioprotective effect of verapamil in acute percutaneous transluminal coronary angioplasty
    692. Cardioprotective effect of natural antioxidants: evaluation in cultured cardiomyocytes
    693. Cardioprotective Effect of Ischemic Preconditioning: Relationship between Intracellular Glycogen and Protein Kinase C
    694. Weight reduction and Cardioprotective effects of phytoestrogens in rats
    695. Insights in the Cardioprotective Mechanism of the New Drug R56865
    696. Acetoacetate: A Cardioprotective Antioxidant
    697. Beta blockers as Cardioprotective agents: Part II-Focus on prevention of sudden cardiac death
    698. Dexrazoxane (ICRF-187): a Cardioprotective agent during anthracycline chemotherapy
    699. Objective assessment of “Cardioprotective” efficacy as a prognostic guide to management of mildly symptomatic revascularizable coronary artery disease
    700. Do sevoflurane and propofol have Cardioprotective properties? A study in patients undergoing off-pump coronary artery bypass graft surgery
    701. Chronic administration of allopurinol fails to exert any Cardioprotective effect in rats submitted to permanent coronary artery ligation
    702. Synthetic and structural studies on carbohydrate-derived Cardioprotective and anticancer agents.
    703. Cardioprotective effect of exogenous creatine phosphate in acute hemorrhage
    704. The differential Cardioprotective effects of nucleoside transport inhibitor on moderate and deep hypothermic ischemia with cold cardioplegia
    705. Cardioprotective effect of monophosphoryl lipid A is mediated by opening KATPchannels in rabbit heart
    706. Cardioprotective effect of intracoronary nifedipine during percutaneous transluminal coronary angioplasty. A French double-blind cross-over multicentre study
    707. Cardioprotective effects of a new fluorine-containing synthetic activator of ATP-dependent potassium channels
    708. Thermal behaviour and binary phase diagram of (S)-(+)-4, 4′-(1-methyl-1, 2-ethandiyl)-bis-(2, 6-piper-azinedione)(dexrazoxane), a Cardioprotective agent, and of its …
    709. Fe-EDTA-bisamide and Fe-ADR-925, the iron-bound hydrolysis product of the Cardioprotective agent dexrazoxane, cleave DNA via the hydroxyl radical
    710. The Cardioprotective effect of a new Soviet synthetic analog of the endogenous opioids in stress due to total myocardial ischemia and its mechanisms
    711. Cardioprotective conditioning with glucose and insulin prior to cardiac surgery involving ischaemic cold arrest.
    712. Direct Cardioprotective effects or coronary vasorelaxant action of cromakalim hyperpolarizing cardioplegia?
    713. Do endogenous opioid peptides participate in the realization of the Cardioprotective effect of adaptation?
    714. Determination of plasma concentration of the Cardioprotective preparation histochrome
    715. Receptive Cardioprotective actions of a calcium antagonist and a beta-adrenergic receptor antagonist
    716. A quantitative structure–activity relationship study of the rate of imide hydrolysis as a predictive model for the hydrolysis-activation of analogs of the Cardioprotective …
    717. The Cardioprotective effect of the ischemic preconditioning of rat cardiac fibroblast [J]
    718. Cardioprotective effect of aladotril, a mixed inhibitor of atriopeptidase and ace, in rats with myocardial infarction. Comparison with captopril
    719. Cardioprotective effects of increased myocardial glycogen stores and β-blockers in cardiac surgery
    720. Mechanisms of Cardioprotective effect of estradiol
    721. Cardioprotective Effect of Calcium Preconditioning and Its Relation to Protein Kinase C in Isolated Perfused Rabbit Heart
    722. Cardioprotective effect of emoxipine in reconstructive coronary artery surgery
    723. Ergometric evaluation of the Cardioprotective effect of pindolol in coronary disease. Comparison of 2 galenic forms
    724. An experimental study on Cardioprotective effect of Astragalus membranaceus on ischemic/reperfusion myocardium in isolated rabbit hearts
    725. Influence of β‐adrenoceptor tone on the Cardioprotective efficacy of adenosine A1 receptor activation in isolated working rat hearts
    726. The participation of prostanoids in the realization of the Cardioprotective, antistressor and anti-arrhythmic effects of enkephalins
    727. Did naproxen’s Cardioprotective effect skew safety data on rofecoxib?
    728. Cardioprotective effect of energostim during occlusion of coronary artery
    729. Cardioprotective Effect of Intracoronary Diltiazem in Myocardial Ischaemia Induced by Percutaneous Transluminal Coronary Angioplasty
    730. The Cardioprotective action of the anticonvulsant preparation sodium valproate in disorders of cardiac contractile function caused by acute myocardial infarct in rats
    731. Cardioprotective effect of osmotic agents.
    732. Should a modern antihypertensive drug possess Cardioprotective properties?
    733. The Cardioprotective effects of diazoxide induced preconditioning against hypoxia-reoxygenation injury in cultured immature rat cardiomyocytes
    734. Cardioprotective effect of hormone replacement therapy: Authors’ reply
    735. The role of opioid system in realisation of Cardioprotective effect of adaptation
    736. Cardioprotective and cardio-reparative drugs
    737. Potential antiarrhythmic and Cardioprotective agents based on adenosine
    738. Mechanism of hydrolysis-activation of the Cardioprotective antioxidant dexrazoxane and identification of more effective analogs by development of a quantitative …
    739. On the Cardioprotective effect of adenosine.
    740. Advances in Australian research into the potential Cardioprotective properties of wine.
    741. Cardioprotective AND CEREBROPROTECTIVE EFFECT OF LIPOCORTIN-LIKE SUBSTANCES
    742. Cardioprotective functions by cardiac fibroblasts
    743. Cardioprotective effect of lignan-enriched Sheng Mai San
    744. Cardioprotective effects of prostacyclin analogues
    745. Cardioprotective effects of ischemic preconditioning
    746. Cardioprotective effect of Lidera erythrocarpa against oxidative stress-induced cell death
    747. The Cardioprotective effect of perindopril in rats with experimental cardiosclerosis
    748. Potential mechanisms of the Cardioprotective effects of beta blockade
    749. Beta blockers as Cardioprotective agents: Part I-Insights into mechanisms of action
    750. The role of HSP70 and Ca (2+)-pump from the myocardial sarcoplasmic reticulum in Cardioprotective effects during adaptation to physical load in rats
    751. Spectrophotometric determination of the Cardioprotective drug GP531 in human plasma
    752. Ramipril: Cardioprotective activity goes beyond BP reduction
    753. Ischemic preconditioning and the mechanism of its Cardioprotective effect.
    754. Evaluation of the Cardioprotective effect of bispiperazinedione ICRF-187 (Cardioxane) in patients treated with anthracyclines–an echocardiographic study
    755. Cardioprotective effect of Lidera erythrocarpa against oxidative stress-induced cell death
    756. MnDPDP: MRI contrast agent with Cardioprotective properties?
    757. The future of converting enzyme inhibitors as Cardioprotective agents
    758. Cardioprotective effects of coronary sinus retroperfusion during LAD angioplasty
    759. Cardioprotective Effects of Postmenopausal Estrogen Therapy
    760. THE Cardioprotective INTENT OF CARDIAC NATRIURETIC PEPTIDES
    761. The Cardioprotective Effects of Ibuprofen in Experimental Models of Ischemic Heart Disease.
    762. Cardioprotective effect of drugs with antioxidant activity in acute cerebral ischemia
    763. AN INVESTIGATION OF THE ROLE OF MITOCHONDRIA IN THE Cardioprotective ACTION OF CALCIUM ANTAGONISTS.
    764. Cardioprotective Effect by Preconditioning with Calcium-free Solution
    765. Cardioprotective actions of bradykinin in the normal and hypertrophied myocardium.
    766. Cardioprotective EFFECT OF REPEATED BRIEF ISCHEMIC PRECONDITIONING
    767. Cardioprotective efficacy of amifostine (WR-2721) in adriamycine-treated rats
    768. Cardioprotective effect of hormone replacement therapy. Benefits women with established cardiovascular disease.
    769. The Cardioprotective efficacy of cariporide as an adjunct in different pH cardioplegia
    770. Cardioprotective effect of trimetazidine in elderly patients with coronary artery disease
    771. Potential Cardioprotective properties of central glutamatergic modulators during exercise
    772. Modulation of Sarcoplasmic Reticulum Calcium Release as A Cardioprotective Strategy
    773. Current Advances in ACE Inhibitor Captopril: Cardioprotective Effects
    774. Cardioprotective effect of chronic treatment with statins prior to percutaneous coronary intervention
    775. Molecular Basis for the Cardi